Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
clinical trials
life sciences
national blog main
boston
boston blog main
abaloparatide
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
amgen
aminolevulinic acid
andrew berens
avapritinib
biotech
blueprint medicines
boston top stories
cancer
cannabis
deciphera pharmaceuticals
drugs
europe blog main
europe top stories
european commission
games
gastrointestinal stromal tumor
gist
givosiran
gleevec
government
health
imatinib
marijuana
medical marijuana
microsoft
microsoft kinect
national
onpattro
osteoporosis
patisiran
What
approval
5
×
drug
5
×
medicine
5
×
fda
announced
nod
seek
administration
ago
aid
alnylam
amgen
amgen’s
app
approved
based
blueprint
called
cancer
cannabis
carries
cbd
chasing
chemical
companies
company
compound
contains
deadly
deciphera
derived
developed
digital
driving
earlier
epidiolex
epilepsy
estimated
europe
european
Language
unset
Current search:
medicine
×
drug
×
approval
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@techcrunch.com
5 years ago
With CBD, marijuana-based medicine gets its first greenlight from the FDA
@venturebeat.com
8 years ago
This Microsoft Kinect-powered physical therapy app is FDA-approved